COVID-19 Briefing Materials: Global Health and Crisis Response (McKinsey & Company, April 13, 2020, 91p)
An extensive analysis with many charts and graphs on the state of the science, 9 scenarios on how the situation might evolve, planning and managing responses (for resilience, supply chains, employees, and customers), state and local governments, challenges to emerging economies, and sector-specific impacts. The 9 scenarios involve the virus contained vs. resurgence vs. rapid escalation (X-axis) and economic downturn, slow growth, and economic renewal (Y-axis). In the service of hope, more than 80 vaccine candidates and 130 therapeutic candidates are being considered.
Also see: COVID-19 Implications for Business: Executive Briefing (McKinsey & Company, April 13, unpaginated; updated every few weeks).